3-(4-(4-(2-(3-((dimethylamino)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl)phenyl)-1,1-dimethylurea(CAS: 942918-07-2)

The compound has a crystalline form with a molecular weight of approximately 769.56 g/mol. It exhibits low solubility in water but good solubility in common organic solvents like DMSO and DMF. The compound is moderately reactive, especially under basic conditions. It is stable under normal storage conditions but may degrade under acidic conditions or prolonged exposure to light.

The compound is synthesized through a multistep process involving the condensation of an ethyl pyrazole with a 2-(3-(dimethylamino)methyl)phenyl-1H-pyrrolo[2,3-b]pyridine derivative. This is followed by a coupling reaction with a 4-(4-(2-(3-((dimethylamino)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrrolo[1,2-a]pyrimidin-2(3H)-yl)benzaldehyde, using a palladium catalyst in the presence of a base. The final step involves the formation of the urea linkage.

The compound is primarily used in the pharmaceutical industry for drug development, specifically in the synthesis of potential antiviral and anticancer agents. It may also find applications in the polymer industry for developing new functional materials and in the sensor and semiconductor industries for novel device fabrication.

When handling this compound, it is important to wear appropriate personal protective equipment (PPE), including gloves, lab coat, and safety goggles. The compound should be handled in a well-ventilated area or a fume hood to minimize inhalation risk. Spills should be cleaned up using appropriate absorbent materials. Always refer to the Safety Data Sheet (SDS) for detailed handling and disposal information. The compound is not considered a hazardous material under normal conditions, but care should be taken to avoid contact with eyes, skin, and inhalation of fumes.